We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLD icon
226
Prologis
PLD
$138B
$6.22M 0.11%
96,474
+88,174
+1,062% +$5.76M
RDUS
227
DELISTED
Radius Health, Inc.
RDUS
$6.2M 0.11%
195,000
+53,000
+37% +$1.66M
RVTY icon
228
Revvity
RVTY
$12.3B
$6.18M 0.11%
84,461
+42,461
+101% +$3.05M
EOG icon
229
EOG Resources
EOG
$78B
$6.08M 0.11%
56,352
-62,412
-53% -$6.29M
KLAC icon
230
KLA
KLAC
$275B
$6.08M 0.11%
578,420
-181,570
-24% -$1.91M
WRK
231
DELISTED
WestRock Company
WRK
$6.05M 0.1%
95,748
-37,543
-28% -$2.28M
BA icon
232
Boeing
BA
$165B
$6.02M 0.1%
20,399
-61,855
-75% -$16.7M
SGEN
233
DELISTED
Seagen Inc. Common Stock
SGEN
$5.99M 0.1%
112,000
+89,000
+387% +$5.2M
BLK icon
234
Blackrock
BLK
$164B
$5.99M 0.1%
11,650
+651
+6% +$316K
BKNG icon
235
Booking.com
BKNG
$138B
$5.96M 0.1%
85,775
+6,225
+8% +$451K
NFLX icon
236
Netflix
NFLX
$292B
$5.96M 0.1%
310,250
+7,140
+2% +$137K
IBN icon
237
ICICI Bank
IBN
$106B
$5.94M 0.1%
610,100
+67,100
+12% +$618K
ADP icon
238
Automatic Data Processing
ADP
$100B
$5.87M 0.1%
50,105
-8,175
-14% -$935K
PNC icon
239
PNC Financial Services
PNC
$100B
$5.87M 0.1%
40,685
-7,862
-16% -$1.09M
PTLA
240
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.87M 0.1%
120,500
-8,000
-6% -$405K
VIAB
241
DELISTED
Viacom Inc. Class B
VIAB
$5.86M 0.1%
190,099
+165,808
+683% +$4.5M
GS icon
242
Goldman Sachs
GS
$313B
$5.85M 0.1%
22,953
+5,586
+32% +$1.37M
WBA
243
DELISTED
Walgreens Boots Alliance
WBA
$5.81M 0.1%
80,030
+5,511
+7% +$388K
BKR icon
244
Baker Hughes
BKR
$56.8B
$5.71M 0.1%
180,499
-23,260
-11% -$746K
TECH icon
245
Bio-Techne
TECH
$11.2B
$5.7M 0.1%
176,000
-106,000
-38% -$3.37M
GG
246
DELISTED
Goldcorp Inc
GG
$5.7M 0.1%
445,370
+65,773
+17% +$850K
RTN
247
DELISTED
Raytheon Company
RTN
$5.68M 0.1%
30,210
+2,245
+8% +$419K
PNW icon
248
Pinnacle West Capital
PNW
$12.9B
$5.65M 0.1%
66,295
-104,672
-61% -$9.24M
ESPR
249
DELISTED
Esperion Therapeutics
ESPR
$5.6M 0.1%
85,000
+5,000
+6% +$269K
HWM icon
250
Howmet Aerospace
HWM
$116B
$5.58M 0.1%
266,791
+229,028
+606% +$4.46M

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.